Literature DB >> 28091335

High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study.

A Adenis1, V Dufit1, M Douine1, F Corlin1, G Ayhan1, F Najioullah2, V Molinie3, P Brousse4, G Carles5, V Lacoste6, R Cesaire2, M Nacher1.   

Abstract

Cervical cancer is the second most frequent cancer in women in French Guiana. Studies have shown that populations living in the remote areas of the interior have early sexual debut and that multiple sexual partnerships are common. The objective of the present study was thus to determine the prevalence of human papillomavirus (HPV) infection in these areas. A study was conducted in women aged 20-65 years with previous sexual activity. Women were included on a voluntary basis after using local media and leaders to inform them of the visit of the team. HPV infection was defined by the detection of HPV DNA using the Greiner Bio-One kit. In addition to HPV testing cytology was performed. The overall age-standardized prevalence rate was 35%. There was a U-shaped evolution of HPV prevalence by age with women aged >50 years at highest risk for HPV, followed by the 20-29 years group. Twenty-seven percent of women with a positive HPV test had normal cytology. Given the high incidence of cervical cancer in French Guiana and the high prevalence of HPV infections the present results re-emphasize the need for screening for cervical cancer in these remote areas. Vaccination against HPV, preferably with a nonavalent vaccine, also seems an important prevention measure. However, in this region where a large portion of the population has no health insurance, this still represents a challenge.

Entities:  

Keywords:  Epidemiology; French Guiana; HPV; prevalence

Mesh:

Substances:

Year:  2017        PMID: 28091335      PMCID: PMC9507840          DOI: 10.1017/S0950268816003319

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  20 in total

1.  Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities.

Authors:  P Londesborough; L Ho; G Terry; J Cuzick; C Wheeler; A Singer
Journal:  Int J Cancer       Date:  1996-10-21       Impact factor: 7.396

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

3.  Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.

Authors:  Gudrun Broberg; Dorte Gyrd-Hansen; Junmei Miao Jonasson; Mare-Liis Ryd; Mikael Holtenman; Ian Milsom; Björn Strander
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

4.  What happens when organization of cervical cancer screening is delayed or stopped?

Authors:  Elsebeth Lynge; Lene Bjørk Clausen; Romain Guignard; Paul Poll
Journal:  J Med Screen       Date:  2006       Impact factor: 2.136

5.  What is driving the HIV epidemic in French Guiana?

Authors:  Mathieu Nacher; V Vantilcke; M C Parriault; A Van Melle; M Hanf; G Labadie; M Romeo; L Adriouch; G Carles; P Couppié
Journal:  Int J STD AIDS       Date:  2010-05       Impact factor: 1.359

Review 6.  [Anti-papillomavirus vaccines and prevention of cervical cancer: progress and prospects].

Authors:  Sébastien Hantz; Sophie Alain; François Denis
Journal:  Presse Med       Date:  2005-06-04       Impact factor: 1.228

7.  Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test.

Authors:  Thomas C Wright; Mark H Stoler; Catherine M Behrens; Abha Sharma; Guili Zhang; Teresa L Wright
Journal:  Gynecol Oncol       Date:  2015-01-08       Impact factor: 5.482

8.  Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.

Authors:  Monica Molano; Adriaan Van den Brule; Martyn Plummer; Elisabete Weiderpass; Hector Posso; Annie Arslan; Chris J L M Meijer; Nubia Muñoz; Silvia Franceschi
Journal:  Am J Epidemiol       Date:  2003-09-01       Impact factor: 4.897

Review 9.  Global burden of human papillomavirus and related diseases.

Authors:  David Forman; Catherine de Martel; Charles J Lacey; Isabelle Soerjomataram; Joannie Lortet-Tieulent; Laia Bruni; Jerome Vignat; Jacques Ferlay; Freddie Bray; Martyn Plummer; Silvia Franceschi
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

10.  Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.

Authors:  Didier Riethmuller; Anne-Carole Jacquard; Jean Lacau St Guily; François Aubin; Xavier Carcopino; Pierre Pradat; André Dahlab; Jean-Luc Prétet
Journal:  BMC Public Health       Date:  2015-05-02       Impact factor: 3.295

View more
  4 in total

1.  Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana.

Authors:  Antoine Adenis; Valentin Dufit; Maylis Douine; Jerome Ponty; Laure Bianco; Fatiha Najioullah; Odile Kilié; Dominique Catherine; Nadia Thomas; Jean Luc Deshayes; Paul Brousse; Gabriel Carles; Claire Grenier; Vincent Lacoste; Vincent Molinie; Raymond Cesaire; Mathieu Nacher
Journal:  BMC Womens Health       Date:  2018-01-24       Impact factor: 2.809

2.  High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana.

Authors:  Sylvie Abel; Fatiha Najioullah; Jean-Luc Voluménie; Laetitia Accrombessi; Gabriel Carles; Dominique Catherine; Déborah Chiappetta; Cyril Clavel; Akua Codjo-Sodokine; Myriam El Guedj; Janick Jean-Marie; Vincent Molinié; Sandrine Pierre-François; Sofia Stegmann-Planchard; Vincent Vantilcke; Tania Vaz; Mathieu Nacher; André Cabié; Raymond Césaire
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

3.  Incidence and mortality of cervical cancer in French Guiana: Temporal and spatial trends.

Authors:  Laure Manuella Imounga; Juliette Plenet; Sophie Belliardo; Elie Chow Chine; Antoine Adenis; Mélanie Gaillet; Nadia Thomas; Céline Michaud; Véronique Servas; Pierre Couppié; Kinan Drak Alsibai; Mathieu Nacher
Journal:  Public Health Pract (Oxf)       Date:  2021-05-16

4.  Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).

Authors:  Clarisse Joachim; Jacqueline Véronique-Baudin; Laure Desroziers; Édouard Chatignoux; Sophie Belliardo; Juliette Plenet; Jonathan Macni; Stephen Ulric-Gervaise; Jessica Peruvien; Bernard Bhakkan-Mambir; Jacqueline Deloumeaux
Journal:  BMC Cancer       Date:  2020-07-10       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.